HCW Biologics Confirms 1-for-40 Reverse Stock Split Strategy

New York, Wednesday, 2 April 2025.
HCW Biologics initiates a 1-for-40 reverse stock split effective 11 April 2025 to maintain Nasdaq listing, adjusting issued shares from 44.9 million to approximately 1.1 million.